🔗 Share this article

A shadow market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Experimental Drug Acquiring Traction Via Social Media

The experimental drug, which remains in research studies, is being promoted by online personalities for its alleged weight-reducing effects. Viewers are encouraged to contact these profiles privately for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust trade exists on messaging services, where groups with thousands of participants share “before and after” images, administration instructions and claims of rapid UK delivery. Vendors promote the substance there before redirecting buyers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

However, doctors and chemists have warned that the sale of what is still an unapproved drug in the UK is worrisome and could result in users injecting substances of uncertain source.

Several experts said the demand for the experimental drug could be connected to the rising cost of approved slimming products such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still breach medicines, advertising, and customer regulations, potentially leading to penalties, legal action or imprisonment.

Platform Response and Content Removal

According to TikTok, the service has removed problematic content and banned related keywords and search suggestions. The company stated it was committed to keeping the service secure and allocating resources in enhancing compliance measures.

Digital Trading Operations

Investigations also discovered communities with up to 9,000 participants marketing the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays channels with numerous of members, filled with images of slimming results, glowing testimonials and step-by-step instructions for preparing or injecting at home.

After minutes of joining one community, a seller posted WhatsApp details, where the majority of purchases occur. The vendor sent an guidebook and promised delivery within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one asked about body mass, health issues or past usage.

Product Information and Costs

Within these groups, messages show dark colored packages with postal service labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When asked how much time a pen should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for Telegram stated it actively moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting substances they can’t verify. Even if the research behind this drug is sound, these digital products may not include what they claim,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent price rises for authorized slimming medications such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she said.

Her team has previously encountered patients harmed by personal administration from unverified sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may expose users to potentially serious health risks”.